Amy Feldman

In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here

Cadence reached a $1.2 billion valuation by using AI to track seniors' chronic health conditions and improve their care. C

Scheduling doctor appointments is its own form of hell for both physicians and patients. Assort Health's AI fix helped it raise its third venture round in 14 months.

Assort Health cofounders Jeff Liu (left) and Jon WangAssort Health Scheduling doctor appointments is its own form of hell for both physicians and patients.

In this week's edition of InnovationRx, we look at AbbVie's new megadeal, an agentic AI startup saving Medicare $2 million a week, how new student loan rules could degrade healthcare and more.

In this week's edition of InnovationRx, we look at Axsome's growing pipeline, HistoSonics innovative cancer treatment, state litigation over Medicaid work requirements, and more.

The AI juggernaut is all-in on the healthcare industry, launching three new products in the last six months. But it needs to make sure ChatGPT is accurate enough for the millions of people who already use it for health advice.

In this week's edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI's healthcare push, Vertex's $10 billion purchase of Crinetics, and more.

When OpenAI wants to sell the country’s biggest health systems on its healthcare ambitions, it often brings in one person a hospital CEO won’t ignore: Sam Altman.

In this week's edition of InnovationRx, Thyme Care gets new leadership, the intestinal illness spreads, Chai Discovery confirms its $400 million raise, and more.